Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder

Psychopharmacology Bulletin

Volumn 32, Issue 4, 1996, Pages 569-578

  Laird, Lyle K ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Comorbid conditions; Obsessive compulsive disorder; Polypharmacotherapy; Serotonin reuptake inhibitors; Treatment refractory

Indexed keywords

BUSPIRONE; CLOMIPRAMINE; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; LITHIUM; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

ADJUVANT THERAPY; CLINICAL PRACTICE; CONFERENCE PAPER; DOPAMINE BLOOD LEVEL; DRUG MIXTURE; FOOD AND DRUG ADMINISTRATION; HUMAN; NEUROTRANSMISSION; OBSESSION; PREDICTION; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN SYNDROME; TREATMENT PLANNING; WITHDRAWAL SYNDROME;

HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN;

EID: 0030454708     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Ackerman, DL; Greenland, S; Bystritsky, A; Morgenstern, H; and Katz, R. Predictors of treatment response in obsessivecompulsive disorder Multivariate analyses from a multicenter trial of clomipramine. J. Clin. Psychopharmacol. 14:247-254, 1994.